Immunogenicity against the BNT162b2 mRNA COVID-19 Vaccine in Rheumatic Disease Patients Receiving Immunosuppressive Therapy

OBJECTIVE: To investigate the serum total antibody (immunoglobulin M and immunoglobulin G) titre against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein receptor-binding domain following BNT162b2 messenger ribonucleic acid (mRNA) coronavirus disease 2019 (COVID-19) vaccina...

Descripción completa

Detalles Bibliográficos
Autores principales: Sugihara, Koichi, Wakiya, Risa, Shimada, Hiromi, Kameda, Tomohiro, Nakashima, Shusaku, Kato, Mikiya, Miyagi, Taichi, Mizusaki, Mao, Mino, Rina, Nomura, Yumi, Inoo, Masayuki, Kadowaki, Norimitsu, Dobashi, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334253/
https://www.ncbi.nlm.nih.gov/pubmed/35466168
http://dx.doi.org/10.2169/internalmedicine.9223-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334253/
https://www.ncbi.nlm.nih.gov/pubmed/35466168
http://dx.doi.org/10.2169/internalmedicine.9223-21

Ejemplares similares